Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIMEKIZUMAB vs BIPERIDEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIMEKIZUMAB vs BIPERIDEN: Safety Overview

Metric BIMEKIZUMAB BIPERIDEN
Total FAERS Reports 2,459 1,808
Deaths Reported 31 180
Death Rate 1.3% 10.0%
Hospitalizations 565 1,008
Average Patient Age 52.9 yrs 45.1 yrs
% Female Patients 59.9% 44.7%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer UCB, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status N/A Discontinued